Diagnostica Stago Offers Flow-based Hemostasis Markers

Diagnostica Stago Offers Flow-based Hemostasis Markers
Mar 25, 2010 11:48am

I had the pleasure of meeting and speaking with Paul Riley, PhD, Manager of Research Use Products, Diagnostica Stago, Inc., New Jersey. Paul said that Stago is now partnering with the advanced research and development company BioCytex to market ready to use flow cytometric assays for hemostasis diagnosis. They can now identify P2Y12 occupancy via the downstream marker VASP , platelet glycoprotein IIb/IIIa occupancy, platelet PAIg, and RBC paroxysmal nocturnal hemoglobinuria (PNH) markers CD 55 and CD 59, among others. This is an exciting new venture for Stago and helps open the door to more extensive platelet activation analysis. For further information, I have attached theĀ Biocytex catalog.

0 Comments

I had the pleasure of meeting and speaking with Paul Riley, PhD, Manager of Research Use Products, Diagnostica Stago, Inc., New Jersey. Paul said that Stago is now partnering with the advanced research and development company BioCytex to market ready to use flow cytometric assays for hemostasis diagnosis. They can now identify P2Y12 occupancy via the downstream marker VASP , platelet glycoprotein IIb/IIIa occupancy, platelet PAIg, and RBC paroxysmal nocturnal hemoglobinuria (PNH) markers CD 55 and CD 59, among others. This is an exciting new venture for Stago and helps open the door to more extensive platelet activation analysis. For further information, I have attached theĀ Biocytex catalog.

Leave A Comment

You must be logged in to Comment - Sign In